From: Blood biomarkers role in acute ischemic stroke patients: higher is worse or better?
Variable (Units) / Quartiles | Site | D1 | D2 | D3 | D4 |
---|---|---|---|---|---|
(OR; 95% CI) | (OR; 95% CI) | (OR; 95% CI) | (OR; 95% CI) | (OR; 95% CI) | |
ESR (mm) | Â | Â | Â | Â | Â |
Q1 (< 10) n = 23 | 1 | 1 | 1 | 1 | 1 |
Q2 [10 – 16) n = 30 | 0.650 (0.212-1.993) | 0.473 (0.149-1.501) | 2.115 (0.666-6.715) | 2.625 (0.478-14.428) | 7.981 (0.383-166.240) |
Q3 [16 – 30) n = 19 | 0.758 (0.218-2.632) | 0.945 (0.277-3-230) | 1.319 (0.380-4.577) | 2.800 (0.452-17.318) | 6.714 (0.283-159.527) |
Q4 [> 30) n = 27 | 1.040 (0.339-3.190) | 0.765 (0.246-2.381) | 1.538 (0.488-4.853) | 5.250 (1.002-27.514)* | 0.855 (0.015-48-430) |
Fibrinogen (mg/dL) | Â | Â | Â | Â | Â |
Q1 (< 303) n = 24 | 1 | 1 | 1 | 1 | 1 |
Q2 [303 – 368) n = 25 | 1.333 (0.415-4.281) | 1.366 (0.411-4.539) | 0.708 (0.203-2.470) | 2.750 (0.479-15.794) | 0.958 (0.057-16.243) |
Q3 [368 – 462) n = 24 | 0.824 (0.242-2.797) | 1.214 (0.358-4.124) | 0.667 (0.190-2.338) | 5.500 (1.027-29.451)* | 2.091 (0.177-24.734) |
Q4 [> 462) n = 25 | 2.167 (0.682-6.883) | 1.619 (0.493-5.319) | 0.500 (0.147-1.697) | 4.278 (0.789-23.193) | 2.000 (0.169-23.623) |
Platelets (value x 10.e3/uL) | Â | Â | Â | Â | Â |
Q1 (< 189) n = 25 | 1 | 1 | 1 | 1 | 1 |
Q2 [189 – 256) n = 25 | 0.434 (0.138-1.371) | 0.826 (0.246-2.776) | 1.000 (0.291-3.437) | 1.000 (0.278-3.598) | 13.683 (0.674-277.964) |
Q3 [256 – 323) n = 25 | 0.519 (0.167-1.611) | 1.417 (0.444-4.521) | 0.583 (0.178-1.906) | 0.059 (0.003-1.175)* | 3.122 (0.114-85.732) |
Q4 [> 323) n = 25 | 1.000 (0.330-3.033) | 1.962 (0.621-6.193) | 0.495 (0.153-1.606) | 2.032 (0.608-6.797) | 1.000 (0.018-56.631) |
Blood Albumin (g/dL) | Â | Â | Â | Â | Â |
Q1 (< 2.9) n = 25 | 1 | 1 | 1 | 1 | 1 |
Q2 [2.9 – 3.4) n = 24 | 1.504 (0.488-4.639) | 3.150 (0.815-12.168) | 0.227 (0.053-0.981)* | 1.059 (0.306-3.658) | 5.677 (0.243-132.298) |
Q3 [3.4 – 3.8) n = 22 | 1.273 (0.403-4-19) | 5.250 (1.351-20.396)* | 0.164 (0.038-0.711)* | 0.406 (0.091-1.817) | 3.558 (0.129-98.252) |
Q4 [> 3.8) n = 25 | 0.402 (0.102-1.349) | 3.500 (0.921-13-307) | 0.205 (0.048-0.870)* | 0.643 (0.173-2.388) | 7.933 (0.366-172.044) |
Triglycerides (mg/dL) | Â | Â | Â | Â | Â |
Q1 (< 78) n = 25 | 1 | 1 | 1 | 1 | 1 |
Q2 [78 – 111) n = 26 | 2.844 (0.913-8.861) | 1.474 (0.398-5.452) | 0.833 (0.218-3.179) | 0.273 (0.072-1.034) | 0.958 (0.124-7.383) |
Q3 [111 – 162) n = 26 | 1.778 (0.579-5.457) | 9.000 (2.487-32.567)* | 0.132 (0.037-0.471)* | 0.273 (0.072-1.034) | 0.460 (0.039-5.418) |
Q4 [> 162) n = 26 | 0.323 (0.084-1.237) | 1.474 (0.398-5.454) | 0.679 (0.183-2.510) | 0.273 (0.072-1.034) | 0.460 (0.039-5.418) |